A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1173
https://www.valueinhealthjournal.com/article/S1098-3015(13)03078-7/fulltext
Title :
A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03078-7&doi=10.1016/j.jval.2013.08.1173
First page :
A507
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1025